Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
37 studies found for:    Northwestern AND Cirrhosis
Show Display Options
Rank Status Study
1 Recruiting Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
Conditions: Thrombocytopenia;   Cirrhosis
Intervention: Device: TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
2 Withdrawn Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: Non-myeloablative Hematopoietic Stem Cell Transplantation
3 Completed
Has Results
HRQoL in the Low MELD Pre-tx Population
Condition: Cirrhosis of the Liver
Intervention:
4 Not yet recruiting Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Condition: Cirrhosis
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Simvastatin
5 Completed Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
Conditions: Portal Hypertension;   Hepatic Encephalopathy;   Cirrhosis
Intervention: Drug: lactulose
6 Completed Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.
Condition: Obesity
Intervention:
7 Active, not recruiting A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Conditions: Liver Diseases;   Hepatocellular Cancer;   Endstage Liver Disease;   Liver Cirrhosis
Intervention: Behavioral: donor pain management/ Pre-operative OR Set-up
8 Terminated Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
Conditions: Complication of Transplanted Liver;   Hepatitis C, Chronic
Intervention:
9 Enrolling by invitation Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
Conditions: Liver Disease;   Cardiovascular Disease
Intervention: Drug: Cholate testing
10 Recruiting Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Conditions: Hepatitis B;   Hepatitis B, Chronic
Intervention:
11 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
12 Terminated Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
13 Terminated Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
14 Enrolling by invitation A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Condition: Hepatitis C Virus Infection
Intervention: Drug: Sofosbuvir
15 Active, not recruiting Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Condition: Hypertension, Portal
Interventions: Drug: GR-MD-02;   Drug: Placebo
16 Recruiting Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: SEL;   Drug: Placebo
17 Recruiting Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavarin
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/VEL;   Drug: RBV
18 Completed Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
Conditions: Hepatic Encephalopathy;   Liver Failure;   Hepatitis, Chronic;   Liver Cirrhosis
Interventions: Device: MARS;   Drug: Standard Medical Therapy
19 Recruiting A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
Condition: Hepatitis C Virus (HCV)
Intervention: Drug: Glecaprevir/Pibrentasvir
20 Completed Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA)

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.